Associate Members

  • AMEGI
  • GBMA
  • MOPI
  • PROGENERICOS
Mexican Association of Generic Medicines Read More
Generic and Biosimilar Medicines Association (Australia) Read More
Malaysian Organisation of Pharmaceutical Industries Read More
Brazilian Generic Medicine Drugmakers Association Read More

Print

News

  • Ingrid Schwarzenberger, new Chair of the IGBA Biosimilars Committee

    June 13 2017 - IGBA is pleased to announce today the nomination of Ingrid Schwarzenberger, Head Global Regulatory Affairs at Sandoz Biopharmaceuticals, as the new Chair of the IGBA Biosimilars Committee. Ingrid has played a leading role in the establishment of Read More
  • European Experience and Evidence of Physician-led Switching of Biological Medicines Give Hope to Patients around the World

    March 14, 2017 - On 9th March, IFPMA launched jointly with EFPIA and EBE a position paper entitled Considerations for physicians on switching decisions regarding biosimilars. Physician-led switching of biological medicines is a well-known medical practice. Although data on the frequency Read More
  • IGBA Statement on the Final Report of the United Nations Secretary General’s High Level Panel on Access to Medicines

    November 15, 2016 – Geneva, Switzerland – The International Generic and Biosimilar Medicines Association (IGBA) believes that generic and biosimilar medicines can play a fundamental role in improving access to high quality medicines for patients worldwide. Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

Joint 23rd Medicines for Europe and 20th IGBA Annual Conference

Joint 22nd Medicines for Europe and 19th IGBA Annual Conference

18th Annual IGPA Conference

Contact Info

IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

Rue d'Arlon, 50
B-1000 Brussels, Belgium

Telephone: +32 (0)2 736 84 11
Fax: +32 (0)2 736 74 38
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.